Scott Michael Palmer, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Vice-Chair for Research in the Department of Medicine
Professor in Immunology
Core Faculty in Innovation & Entrepreneurship
Campus mail 2085 Msrb2 2 Genome Ct, Durham, NC 27710
Phone (919) 684-0245
Email address palme002@mc.duke.edu

Dr. Palmer leads a successful program of clinical, basic and translational research in transplantation and advanced lung diseases. He currently directs the pulmonary research program at the Duke Clinical Research Institute (DCRI) and serves as Vice Chair for Research in the Department of Medicine.

Dr. Palmer has over 150 peer reviewed publications, received numerous awards, including election into the American Society for Clinical Investigation (ASCI) in 2012, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He is also Associate Director of the Clinical Research Training Program at Duke and has personally mentored over 40 pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.

His scientific accomplishments include the first human studies to demonstrate the importance of innate immunity in transplant rejection and completion of a prospective multicenter study that improved CMV prevention after lung transplantation.

Current basic projects in the lab are studying the role of the matrix in the activation of innate immunity in pulmonary transplant rejection, and epithelial injury and repair in the development of toxin induced bronchiolitis obliterans. Translational and human projects are studying predictors of lung transplant survival in the UNOS database, immune monitoring to predict CMV infection and acute rejection after lung transplantation, and the use of novel inhaled antibiotics in lung transplantation. The lab is also using cutting edge whole exome genetic sequencing to identify genetic predictors of transplant rejection.

Dr. Palmer also leads trials coordinated through the DCRI that study the natural history and investigate new treatments for idiopathic pulmonary fibrosis (IPF), chronic lung transplant rejection, and posttransplant cytomegalovirus infection.

Education and Training

  • Fellow, Pulmonary Medicine, Medicine, Duke University, 1996 - 1999
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2000
  • M.D., Duke University, 1993

Publications

Diamond, JM, Porteous, MK, Roberts, LJ, Wickersham, N, Rushefski, M, Kawut, SM, Shah, RJ, Cantu, E, Lederer, DJ, Chatterjee, S, Lama, VN, Bhorade, S, Crespo, M, McDyer, J, Wille, K, Orens, J, Weinacker, A, Arcasoy, S, Shah, PD, Wilkes, DS, Hage, C, Palmer, SM, Snyder, L, Calfee, CS, Ware, LB, Christie, JD, and Lung Transplant Outcomes Group, . "The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia." The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation 35, no. 4 (April 2016): 500-507.

PMID
26856667
Full Text

Durheim, M, Wojdyla, D, Green, C, Keshavjee, S, McCurry, K, Lidor, A, Davis, R, Palmer, S, and Todd, J. "Evaluation of an FVC-Based Definition of Restrictive Chronic Lung Allograft Dysfunction (CLAD) in a Multi-Center Cohort." April 2016.

Full Text

Cantu, E, Diamond, J, Nellen, J, Beduhn, B, Suzuki, Y, Borders, C, Lasky, J, Schaufler, C, Shah, R, Porteous, M, Lederer, D, Kawut, S, Arcasoy, S, Palmer, S, Snyder, L, Hartwig, M, Lama, V, Crespo, M, Wille, K, Orens, J, Shah, P, Weinacker, A, Ware, L, Bellamy, S, and Christie, J. "Redefining Primary Graft Dysfunction after Lung Transplantation." April 2016.

Full Text

Smith, P, Blumenthal, J, Mathew, J, Hoffman, B, Rivelli, S, Durheim, M, and Palmer, S. "Depression, Quality of Life, and Mortality Early Following Lung Transplantation." April 2016.

Full Text

Todd, J, Finlen Copeland, C, Neely, M, and Palmer, S. "FVC and FEV1 Decline in Chronic Lung Allograft Dysfunction (CLAD) Phenotypes." April 2016.

Full Text

Cantu, E, Suzuki, Y, Diamond, JM, Ellis, J, Tiwari, J, Beduhn, B, Nellen, JR, Shah, R, Meyer, NJ, Lederer, DJ, Kawut, SM, Palmer, SM, Snyder, LD, Hartwig, MG, Lama, VN, Bhorade, S, Crespo, M, Demissie, E, Wille, K, Orens, J, Shah, PD, Weinacker, A, Weill, D, Wilkes, D, Roe, D, Ware, LB, Wang, F, Feng, R, Christie, JD, and Lung Transplant Outcomes Group, . "Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk." American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 16, no. 3 (March 2016): 833-840.

PMID
26663441
Full Text

Smith, PJ, Blumenthal, JA, Hoffman, BM, Rivelli, SK, Palmer, SM, Davis, RD, and Mathew, JP. "Reduced Cerebral Perfusion Pressure during Lung Transplant Surgery Is Associated with Risk, Duration, and Severity of Postoperative Delirium." Annals of the American Thoracic Society 13, no. 2 (February 2016): 180-187.

PMID
26731642
Full Text

Blumenthal, JA, Smith, PJ, Durheim, M, Mabe, S, Emery, CF, Martinu, T, Diaz, PT, Babyak, M, Welty-Wolf, K, and Palmer, S. "Biobehavioral Prognostic Factors in Chronic Obstructive Pulmonary Disease: Results From the INSPIRE-II Trial." Psychosomatic medicine 78, no. 2 (February 2016): 153-162.

PMID
26780299
Full Text

DerHovanessian, A, Weigt, SS, Palchevskiy, V, Shino, MY, Sayah, DM, Gregson, AL, Noble, PW, Palmer, SM, Fishbein, MC, Kubak, BM, Ardehali, A, Ross, DJ, Saggar, R, Lynch, JP, Elashoff, RM, and Belperio, JA. "The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome." American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 16, no. 2 (February 2016): 640-649.

PMID
26461171
Full Text

O'Brien, EC, Durheim, MT, Gamerman, V, Garfinkel, S, Anstrom, KJ, Palmer, SM, and Conoscenti, CS. "Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry." Bmj Open Respiratory Research 3, no. 1 (January 11, 2016): e000108-null.

PMID
26835134
Full Text

Pages